First draft genome sequence of Candidozyma auris from a human clinical isolate in a major metropolitan hospital in Lima, Peru
Diego Cuicapuza, Fernando Soto-Febres, Edgar Neyra, Beatriz Bustamante
TL;DR
This paper provides the first draft genome of a fluconazole-resistant Candidozyma auris isolate from a patient in Lima, Peru.
Contribution
The study presents the first genome sequence of C. auris from Peru, highlighting its antifungal resistance.
Findings
A fluconazole-resistant Candidozyma auris isolate was obtained from a clinical sample in Lima, Peru.
The draft genome sequence is reported for this emerging pathogenic yeast.
Abstract
We present the draft genome sequence of a fluconazole-resistant Candidozyma auris isolate obtained from a Peruvian referral hospital. C. auris is an emerging pathogenic yeast of significant public health concern due to its antifungal resistance, particularly in patients with comorbidities.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFungal Infections and Studies · Antifungal resistance and susceptibility · Nail Diseases and Treatments